• logo-cirtec.jpg
    Cirtec Medical
    North America / Private Equity

    Healthcare

    Overview

    Cirtec Medical ("Cirtec") is a leading global provider of outsourced medical device and components design, engineering and manufacturing, headquartered in Minnesota. Cirtec specialises in outsourced solutions for active implantable medical devices. Customers rely on Cirtec’s expertise to provide value-add solutions throughout the entire development cycle to help bring life-enhancing therapies to market.

    The medical device outsourcing (MDO) market is expected to grow at a high single digit rate over the next five years and Cirtec is strategically indexed to the most innovative therapeutic end-markets that are growing at a rate beyond the broader MDO industry.

    Highlights

    • Helping Cirtec expand its capabilities and footprint through the acquisitions of Vascotube, Top Tool and high value intellectual property
    • Recruited William Hawkins (former Medtronic CEO) and William Ellerkamp (former ExtruMed CEO) to the Board of Directors
    • Supporting the business through continued targeted acquisitions within the highly fragmented MDO market
    • Utilising our sector experience and international network to promote Cirtec’s organic growth plans

     

    "We look forward to partnering with 3i. We feel that their approach, sector understanding and international reach makes them the right partner to support the next stage of our growth." Brian Highley, CEO, Cirtec
  • ONE MED.png
    OneMed Group
    Sweden / Private Equity

    Healthcare

    Overview

    OneMed is the leading medical supplies distributor in Northern Europe, serving both public and private customers with reliable, high-quality products in medical supplies, devices and equipment. The business is present in the Nordics, the Baltics, the Netherlands and Central and Eastern Europe.

    We led the buyout of OneMed in December 2010. This provided a platform from which to accelerate OneMed’s consolidation of the industry and drive operational effectiveness throughout the business.

    Highlights

    • Acquisition in 2015 of Bosman, a Dutch player, further strengthened by the acquisition of Lensvelt Medical (2016) and Boeren Medical (2017)
    • Leveraged our international presence and network to access new suppliers to improve supply chain management and sourcing
    • Our track record in healthcare, distribution and logistics supports OneMed’s plan to expand private label sales across Europe
  • GROUPE PONROY.png
    Ponroy Santé Group
    France / Private Equity

    Healthcare

    Overview

    Ponroy Santé Group ("Ponroy")

    is a leader in the Natural Consumer Healthcare industry in Europe. It manufactures, designs and distributes a wide range of products from functional and natural food supplements, to natural personal care products for babies and women through its world class plant in France. Ponroy is well positioned due to its multi-distribution channel strategy and owns several well-known brands including Vitarmonyl, Biolane, Manhaé, Ultrabiotique, Naturémoi and acquired Aragan / Synactifs and Suvéal Duo brands respectively in 2017 and 2018 to strengthen Ponroy’s presence in the pharmacy channel.

    Since inception, Ponroy has grown year double digit each year organically and is well positioned to benefit from the consolidation taking place in this highly fragmented market and will continue to expand its international footprint in Europe, Asia and the Americas.

    Highlights

    • Strong future organic growth expected stemming from global mega trends in natural healthcare and well-being
    • Introduced Philippe Charrier, a seasoned leader in the FMCG and Natural Consumer Healthcare, as President and CEO via our Business Leaders Network
    • Supporting the management team to implementing a complete digital strategy
    • Supporting M&A opportunities using our global network and strong experience which led to the acquisitions of Aragan within a few months of our ownership and Densmore in July 2018
    "We look forward to benefiting from 3i’s strong track record and experience in this sector, as well as its wide international network and its know-how in terms of build-ups." Philippe Charrier, CEO, Ponroy
  • Q HOLDING COMPANY.png
    Q Holding
    North America / Private Equity

    Healthcare

    Overview

    Q Holding is a leading global manufacturer of highly-engineered, fully assembled medical devices and precision-molded elastomeric components used in a broad range of Life Sciences (medical and pharmaceutical) and Electrical Management (industrial, automotive and aerospace) applications. Headquartered in Ohio, it sells products in over 50 countries and has 13 manufacturing locations in North America, EMEA and Asia.

    Q Holding has built a strong reputation as the supplier of choice to provide high-quality mission critical components for medical and harsh environment applications. It has developed longstanding relationships with a broad range of blue-chip customers who value Q’s ability to design and develop customized solutions and manufacture globally.

    Highlights

    • Acquisitions of Degania Medical (Dec. 2016), a leading global manufacturer of catheters and other medical devices and Silicone Altimex (July 2015), a silicone provider of medical device components and pharmaceutical assemblies
    • Strong organic growth driven by favorable trends in medical (preference for minimally invasive therapies) and industrial / auto (content growth, connectivity, IoT) end markets
    • Global manufacturing footprint aligned with customers. New facilities in Mexico, supporting investments in Europe, China and India
    • Experienced management team with longstanding track record of driving innovation in product and service offering
Back to top